AstraZeneca (AZN) receives FDA approval for its BRILINTA tablets to reduce the rate of heart...

|About: AstraZeneca Group plc (AZN)|By:, SA News Editor

AstraZeneca (AZN) receives FDA approval for its BRILINTA tablets to reduce the rate of heart attack in adult patients with acute coronary syndrome. Shares +1.62% AH.